The Philippine Chamber of Commerce and Industry, the country’s largest business organization, has proposed that India pharmaceutical companies put up alternative manufacturing and research facilities in the Philippines to qualify for tariff-free entry to the Asean markets.

“The Philippines should not only be a viable market for cheap Indian medicine, our country could also be an alternative production location for Indian pharmaceutical companies,” said PCCI chairman Miguel Varela.

Premium + Digital Edition

Ad-free access


P 80 per month
(billed annually at P 960)
  • Unlimited ad-free access to website articles
  • Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)

TRY FREE FOR 14 DAYS
See details
See details